1AI 16.7% 0.7¢ algorae pharmaceuticals limited

Ann: NTCELL Phase I IIa Parkinson's trial update, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 47 Posts.
    lightbulb Created with Sketch. 20
    we are now at 2 years post implant. As detailed, patients increase by 4-5 points per year. Therefore all have really responded to the treatment. Some ok,some well, some very well. 
    awaiting the 80 cell results. This is looking more like a treatment "that would extend the disease progression of sufferers beyond the point where they would die of other (natural hopefully) causes" ...
    bring on the medsafe announcement!!!!
    hook the share to a spaceX rocket while you are at it !
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.